Drug Shortage Report for GLN-OLMESARTAN HCTZ
| Report ID | 247976 |
| Drug Identification Number | 02475707 |
| Brand name | GLN-OLMESARTAN HCTZ |
| Common or Proper name | OLMESARTAN HCTZ |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | HYDROCHLOROTHIAZIDE OLMESARTAN MEDOXOMIL |
| Strength(s) | 12.5MG 20MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 90 tablets |
| ATC code | C09DA |
| ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-01-11 |
| Actual start date | 2025-01-11 |
| Estimated end date | 2025-04-14 |
| Actual end date | 2025-05-05 |
| Shortage status | Resolved |
| Updated date | 2025-05-06 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2025-05-06 | English | Compare |
| v6 | 2025-05-05 | French | Compare |
| v5 | 2025-05-05 | English | Compare |
| v4 | 2025-02-11 | French | Compare |
| v3 | 2025-02-11 | English | Compare |
| v2 | 2025-01-17 | French | Compare |
| v1 | 2025-01-17 | English | Compare |
Showing 1 to 7 of 7